| 词条 | Tigilanol tiglate |
| 释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 451562722 | IUPAC_name = | image = EBC-46.svg | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = injected | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|correct|CAS}} | CAS_number = 943001-56-7 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = R1ZJT87990 | KEGG = D11191 | ATCvet = yes | ATC_prefix = L01 | ATC_suffix = XX91 | PubChem = 23627739 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 32079087 | C=30 | H=42 | O=10 | molecular_weight = 562.647 | smiles = CCC(C)C(=O)O[C@@]12[C@@H](C1(C)C)[C@@H]3[C@H]4[C@](O4)([C@H]([C@]5([C@H]([C@]3([C@@H]([C@H]2OC(=O)/C(=C/C)/C)C)O)C=C(C5=O)C)O)O)CO | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C30H42O10/c1-9-13(3)23(33)38-21-16(6)28(36)17-11-15(5)20(32)29(17,37)25(35)27(12-31)22(39-27)18(28)19-26(7,8)30(19,21)40-24(34)14(4)10-2/h9,11,14,16-19,21-22,25,31,35-37H,10,12H2,1-8H3/b13-9+/t14?,16-,17+,18-,19-,21-,22+,25-,27+,28+,29-,30-/m1/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = YLQZMOUMDYVSQR-YUKITULJSA-N }}Tigilanol tiglate (USAN),[1] previously known as EBC-46 is an experimental drug candidate being studied pre-clinically[2] by the Australian company Ecobiotics (specifically its drug discovery subsidiary Qbiotics). It was discovered through an automated screening process of natural products by selecting increasingly purified fractions of plant extracts, based on their ability to produce the desired activity profile. This is then followed by artificial synthesis of the isolated compound to confirm its chemical structure. EBC-46 is a phorbol ester which, along with other related compounds, acts as a protein kinase C regulator.[3] The initial lead came from observation that marsupials found the seed of Fontainea picrosperma unpalatable due to an inflammatory chemical present in reasonably high concentrations. This was identified as 12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tiglian-3-one.[4] EBC-46 is an extract from blushwood berries of Queensland, Australia.[2] See also
References1. ^{{cite web|title=United States Adopted Name (USAN) Drug Finder|url=https://searchusan.ama-assn.org/usan/documentDownload?uri=%2Funstructured%2Fbinary%2Fusan%2Ftigilanol-tiglate.pdf|website=United States Adopted Names|publisher=American Medical Association|accessdate=20 February 2017}} 2. ^1 {{Cite journal | doi = 10.1371/journal.pone.0108887| title = Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models| journal = PLoS ONE| volume = 9| issue = 10| pages = e108887| year = 2014| last1 = Boyle | first1 = G. M. | last2 = d'Souza | first2 = M. M. A. | last3 = Pierce | first3 = C. J. | last4 = Adams | first4 = R. A. | last5 = Cantor | first5 = A. S. | last6 = Johns | first6 = J. P. | last7 = Maslovskaya | first7 = L. | last8 = Gordon | first8 = V. A. | last9 = Reddell | first9 = P. W. | last10 = Parsons | first10 = P. G. | pmid=25272271 | pmc=4182759}} 3. ^{{Cite journal | last1 = Aitken | first1 = A. | doi = 10.1111/j.1095-8339.1987.tb01049.x | title = The activation of protein kinase G by daphnane, ingenane and tigliane diterpenoid esters | journal = Botanical Journal of the Linnean Society | volume = 94 | pages = 247 | year = 1987 | pmid = | pmc = }} 4. ^Tiglian-3-one derivatives. Patent WO 2007/070985 8 : Experimental cancer drugs|Diterpenes|Cyclopropanes|Alcohols|Alkenes|Ketones|Carboxylate esters|Epoxides |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。